We have determined the genomic structure of the mouse fra-1 gene, which consists of four exons and three introns at positions also found in the other members of the fos gene family. Fra-1 is expressed rather highly in the brain and testes of adult mice, and at low levels in most other tissues. Absence of c-Fos leads to signi®cantly reduced serum stimulation of fra-1 expression in gene targeted mouse ®broblasts, demonstrating that mitogen induction of fra-1 is partially mediated by c-Fos/AP-1. A polymorphic (CA) n microsatellite marker was found in intron 2 of fra-1 and used to map the gene to the centromeric region of mouse chromosome 19. Since fra-1 maps to the same genomic region as oc (osteosclerosis), an autosomal recessive disorder leading to the bone remodelling disease osteopetrosis, we tested it as a candidate gene for oc. The segregation of fra-1 in two dierent crosses of mice carrying oc and an allelism test between oc and a targeted disruption of fra-1 demonstrate that fra-1 and oc are two distinct genes rather than oc being a mutant allele of fra-1.
Introduction
AP-1 (activator protein 1) is a sequence-speci®c, dimeric DNA binding protein and transcription factor composed of the products of the jun and fos protooncogenes (Angel and Karin, 1991) . The Jun proteins (c-Jun, JunB and JunD) form homo-and heterodimers, whereas the Fos proteins (c-Fos, FosB, Fra-1 and Fra-2) cannot associate with each other but form stable heterodimers with any of the Jun proteins. Previous analyses have indicated important functions for AP-1 in a multitude of cellular processes such as cell proliferation, dierentiation and development, oncogenic transformation, and the response to DNA damaging agents in eukaryotic organisms from yeast to mammals (Angel and Karin, 1991) . AP-1 activity is inducible by a vast number of extracellular stimuli and is therefore thought to play a central role in signal transduction by coupling extracellular signals to reprogramming the pattern of gene expression. So far, relatively few downstream target genes which mediate its diverse biological functions have been identi®ed. Although many mammalian genes have AP-1 binding site(s) in their promoters, only a few have been demonstrated to be bona ®de AP-1 target genes. These include several matrix metalloproteases such as collagenase I and stromelysin-1 and -2 (Angel and Karin, 1991) .
The cellular immediate early gene fra-1 (Fos-related antigen 1) encodes an AP-1 subunit which belongs to the Fos-subfamily (Cohen and Curran, 1988; Cohen et al., 1989) . The DNA-binding speci®city of Fra-1/Jun heterodimers was found to be indistinguishable from that of c-Fos/Jun heterodimers using several AP-1 sites (Cohen et al., 1989) . Fra-1 exhibits oncogenic potential similar to, but weaker than that of c-Fos, since overexpression in established rat ®broblasts leads to anchorage-independent growth and tumor development in athymic mice (Bergers et al., 1995) . However, unlike c-Fos, Fra-1 lacks a transactivation domain and the entire Fra-1 protein fused to the DNA-binding domain of Gal4 was shown to lack any transcriptional activation function (Suzuki et al., 1991; Wisdom and Verma, 1993; Bergers et al., 1995) . Therefore, fra-1 can not only increase, but also repress total AP-1 activity depending on the status of the other Fos proteins in the cell (Suzuki et al., 1991; Groskopf and Linzer, 1994; Bergers et al., 1995; Welter et al., 1995; Yoshioka et al., 1995) . The transcriptional regulation of fra-1 is unique among members of the fos gene family, since only fra-1 is subject to positive control by AP-1 activity (BruÈ sselbach et al., 1995; Bergers et al., 1995) . The fra-1 gene is induced by ectopic expression of several members of the AP-1 family (c-Fos, v-Fos, FosB, Fra-1 and c-Jun) in several cell types (Bergers et al., 1995; Grigoriadis et al., 1993) . Interestingly, the basal and AP-1 induced expression of fra-1 depends on regulatory sequences not only in the promoter region, but primarily in the ®rst intron which comprises a consensus AP-1 site and two TRE-like elements which dier by one nucleotide from the consensus AP-1 binding sequence (Bergers et al., 1995) . In addition to several AP-1 sites, the fra-1 promoter contains a potential antioxidant response element (ARE) and, unlike c-Fos, is inducible by certain phenolic antioxidants (Yoshioka et al., 1995) . Furthermore, the fra-1 promoter contains ®ve consensus binding sites for members of the HMG-box family of DNA binding proteins such as SRY, the mammalian testis-determining gene, which binds strongly to one of them .
As fra-1 expression appears to be, at least in part, controlled by c-fos, it is conceivable that fra-1 might contribute to the phenotypic eects of overexpression or deletion of c-Fos. It has been shown that mice homozygous for a c-fos null allele develop osteopetrosis, a bone remodelling desease characterised by inecient or absent bone resorption Johnson et al., 1992) . These mutant mice completely lack bone resorbing osteoclasts, which is due to a cellautonomous dierentiation block intrinsic to osteoclast/macrophage progenitors (Grigoriadis et al., 1994) . Intriguingly, overexpression of Fra-1 can substitute for c-Fos, in overcoming the dierentiation block of osteoclasts lacking c-Fos in in vitro co-culture assays (K Matsuo, M Tonko and EFW, unpublished data). Another recessive mutation leading to osteopetrosis, osteosclerosis (oc), also exhibits a defect intrinsic to osteoclasts. However, contrary to c-fos
mice, osteoclasts are present in oc/oc mutant mice, but not functional (Udagawa et al., 1992) . These mice exhibit a mild circling behavior beginning at about 2 weeks, incisor eruption is either delayed or absent, and there is absence of marrow spaces easily detected by radiography. In addition, they lose weight from an age of about 15 days on, and usually die within 3 weeks after birth (Marks et al., 1985; Udagawa et al., 1992) . The gene defective in oc mice remains to be identi®ed, but it has been mapped to the centromeric region of chromosome 19 (Marks et al., 1985; Franchi et al., unpublished) . Here we show that the fra-1 gene also maps to the same region of the genome and therefore, we tested fra-1 as a candidate gene for oc.
Results
Cloning and analysis of the genomic fra-1 locus A cosmid library prepared from mouse (strain 129/Sv) genomic DNA was used to isolate the fra-1 genomic locus. Four clones were isolated from *10 6 colonies screened with a 1.5 kb full length mouse fra-1 cDNA. One of them was further characterised since hybridization to probes from the 5' and 3' region of fra-1 cDNA resulted in a pattern of restriction fragments identical to that of tissue DNA. Detailed restriction mapping and Southern blotting revealed that the *39 kb insert of this cosmid contained the entire fra-1 coding region (*8 kb), *25 kb 5' and *5.4 kb 3' to it (Figure 1) . A 4.5 kb ScaI fragment containing the 5' end and an overlapping 8.1 kb SalI/ NotI fragment containing the 3' end of the fra-1 gene were subcloned and sequenced (Figure 2) . The presence and precise location of 4 exons and 3 introns, which together comprise the whole gene, was established by comparison of this genomic sequence to fra-1 cDNA. Exon/intron boundaries were de®ned by the termination of colinearity with cDNA sequences and all contain the consensus splice donor and acceptor motifs. The sequence analysis also revealed the presence of a CpG-island (a short region rich in the dinucleotide sequence CG in which the CpG : GpC ratio is approximately 1 : 1, Bird, 1987) centered around the transcriptional start site and exon 1 (Figure 1 ). Several AP-1 consensus binding sites in the promoter and intron 1, which were found to be important for the induction of expression of the rat fra-1 gene (Bergers et al., 1995) , are also present in the mouse gene, and their sequence and position have been completely conserved (Figures 1 and 2) .
The ®rst exon of the fra-1 gene, which is 357 nucleotides long (counted from the ®rst transcriptional initiation site de®ned by virtue of homology to the rat fra-1 gene), contains the 5' untranslated region (253 bp) and the region encoding the ®rst 35 amino acids. This is separated by intron 1 (2105 bp) from the second exon encoding 64 amino acids. The third exon encodes 36 amino acids containing the entire basic region of the DNA binding domain and the ®rst leucine of the dimerisation domain, and is the smallest exon of the fra-1 gene. The fourth exon is the largest of all and encodes the last 138 amino acids of the Fra-1 protein, including the remainder of the leucine zipper dimerisation domain. It further contains 630 nucleotides of 3' untranslated region and a consensus polyadenylation site. Intron 2 contains a (CA)n microsatellite marker and is the largest of all (4063 bp), whereas the third intron is only 372 bp long (Figure 2 ). The observed exon sizes correspond well to the *1.7 kb length of the major fra-1 transcript.
We compared the structure of the mouse fra-1 gene to those of the mouse c-fos and fosB, and the mouse and chicken fra-2 gene (Van Beveren et al., 1983; Lazo et al., 1991; Foletta et al., 1994; Nishina et al., 1990) . All four genes of the Fos gene family contain four exons and three introns, whose relative size and the part of the protein they encode is also similar ( Figure  3 ). For example, the basic region of the DNA binding domain is always encoded by the third exon, and the leucine zipper is split among the third and fourth exon. Remarkably, the third exon is of identical size (108 bp) in all four genes ( Figure 3 ). Furthermore, exon 3 encodes exactly the same part of the protein in all four Figure 1 Genomic structure of the mouse fra-1 gene. Upper panel shows a restriction map of the *39 kb insert of cosmid 22 containing the whole coding region and addidional extensive 5' and 3' non-coding sequence. Lower panel shows the part of cosmid 22 which was subcloned into plasmid and sequenced. E1 ± E4, exon 1 to exon 4. Empty boxes represent coding sequence within exon 1-exon 4, and hatched boxes represent 5' and 3' untranslated sequence of exon 1 and exon 4, respectively. Circles represent AP-1 binding sites in the 5' non-coding sequence, exon 1 and intron 1 (open circles=one mismatch; closed circles=no mismatch from AP-1 consensus sequence). The positions of the dinucleotide sequence 5'-CG-3' are indicated. Compared to the reference sequence 5'-GC-3', 5'-CG-3' is underrepresented throughout most of the fra-1 gene, but not in a *1.5 kb fragment around exon 1, which therefore constitutes a CpGisland genes, i.e. the entire basic DNA binding domain and the ®rst leucine of the leucine zipper dimerisation domain. Thus, introns two and three interrupt the protein coding region at the same position in all four genes. Exon 4 invariantly is by far the largest exon, being larger than exon 1 ± 3 together in all four fos genes. In addition, all three introns, again in all four genes, are in phase 0, i.e. they are always located in between two codons rather than interrupting a single codon ( Figure 2 and Van Beveren et al., 1983; Lazo et al., 1991; Nishina et al., 1990) .
Analysis of fra-1 expression in vivo and in vitro
The expression of fra-1 in various mouse tissues was determined by Northern blot analysis. Fra-1 mRNA is present at low levels in most organs tested (Figure 4 ). In contrast, rather high levels of expression were found in the testes and the brain. This result was essentially con®rmed by RNase protection assays (G Bergers and M Busslinger, personal communication). The 4.2 kb fra-1 transcript, which in some situations is less abundant than the 1.7 kb transcript, is highly expressed in the brain, being predominant over the 1.7 kb mRNA in that tissue (Figures 4 and 5) . This transcript presumably has an extended 3' untranslated region, since it cross-hybridises with a genomic probe Figure 2 Nucleotide sequence of the fra-1 gene and of 5' and 3'¯anking regions. The sites of transcriptional initiation at positions +1, +4 and +7, as de®ned by homology to the rat fra-1 gene (Bergers et al., 1995) , are indicated by broken arrows. AP-1 consensus binding sites in the 3' untranscribed region, exon 1 and intron 1 are boxed. The ATG start codon, TGA stop codon, consensus polyadenylation signal and a CA 25 -dinucleotide repeat in intron 2 are underlined. Arrows indicate a pair of PCR primers used to amplify a fragment containing this dinucleotide repeat. Splice donor and -acceptor sites at the exon-intron boundaries are indicated by lower-case letters. The basic region of the DNA binding domain in exon 3 is boxed, and the leucine residues of the dimerisation domain in exon 3 and 4 are circled Figure 3 Comparison of the genomic structures of mouse c-fos, fosB, and fra-1, and the chicken fra-2 gene. Exons are indicated by boxes, and 3' and 5' untranslated regions are hatched. The position of the basic DNA binding domain (B), the leucine residues of the dimerisation domain (L, vertical bars), and the sizes (in bp) of each exon, intron and non-coding region are indicated. Note that the size of exon 3, and the positions of the basic domain and leucine zipper are identical in all four genes of the Fos gene family. E1 ± E4, exon 1 to exon 4; I1 ± I3, intron 1 to intron 3. The structures of the mouse c-fos and fosB, and the chicken fra-2 were taken from Van Beveren et al. (1983) , Lazo et al. (1991) and Nishina et al. (1990) . (The mouse fra-2 gene has also been isolated, but due to lack of overlap between genomic clones, the size of the gene could not be determined. However, it appears to be at least as large as the chicken fra-2 (Foletta et al., 1994) . The size of the 5' untranslated region of the fra-2 transcript is 880 bp in the mouse, but was not determined in the chicken) from a region 3' to the consensus poly-adenylation site (data not shown). In testes, two additional RNA species of *2.5 kb and *5.2 kb are present, which were not commonly found in other tissues except for a weak *5.2 kb band in brain and kidneys (Figure 4) . Interestingly, aberrant transcript sizes speci®c for testes have been observed for a number of genes, such as cras N , c-abl and pim-1 (Wolfes et al., 1989; Cohen et al., 1993) .
The expression of fra-1 in wild-type and c-fos 7/7 3T3 ®broblasts was analysed at various time points after serum stimulation. As described previously (Cohen and Curran, 1988) , the kinetics of fra-1 induction in wildtype cells is delayed and somewhat protracted compared to c-fos and c-jun. Whereas c-fos mRNA levels are signi®cantly increased already 15 min after serum stimulation, an increase of fra-1 transcription is detected only after 45 min, a time when c-fos mRNA levels are already at their peak (Figure 5a ). At 2.5 h after serum stimulation, the transient induction of c-fos transcription is already terminated, since mRNA levels are equal to those of unstimulated cells. In contrast, fra-1 mRNA levels peak only at 1.5 ± 2.5 h after stimulation and remain signi®cantly elevated for at least 12 h (Figure 5a ).
Quanti®cation with a phosphoimager instrument demonstrated that fra-1 mRNA is serum inducible by a factor of 12 compared to unstimulated cells, measured at its peak 1.5 h after addition of 20% serum. Thereafter it gradually declines, but remains elevated by a factor of 46 for at least 12 h (Figure 5c ). In cells lacking c-Fos, fra-1 mRNA levels were greatly reduced at the early stages after serum stimulation and were elevated only *twofold after 1.5 h, as compared to *12-fold in wild-type cells (Figure 5b,c ). Only at 6 h after serum stimulation, the levels observed in Fos- less cells eventually reached those in wild-type cells, which had, however, already declined by a factor of *2 by this time. The kinetics of c-fos serum induction was compared to the`c-fos-dependent' part of fra-1 induction (Figure 5d ). Overall, these two curves look very similar, but the c-fos-dependent induction of fra-1 is delayed relative to induction of c-fos, reaching its peak *45 min later. In summary, serum induction of fra-1 is reduced and signi®cantly delayed in the absence of c-Fos.
Mapping of the fra-1 locus to chromosome 19
Our sequence analysis revealed the presence of a microsatellite (CA)n in the second intron of the mouse fra-1 gene (Figure 2) . A pair of primers allowing ampli®cation of a fragment containing this microsatellite was selected. This primer set allows the ampli®cation of a 134 bp long fragment with C57BL/6 and C57L genomic DNA, and of a 132 bp fragment with AKR and C3H genomic DNA. We have then decided to map the mouse fra-1 gene with the help of the AKXL (between AKR and C57L) and BXH (between C57BL/6 and C3H) recombinant inbred strains sets. As shown in Tables 1 and 2 , no recombinant out of 29 strains was found between fra-1 and D19Mit59, a mouse chromosome 19 centromeric microsatellite (Dietrich et al., 1994) . Thus, they map in the same genetic region of 6.2 cM for a 95% con®dence interval (Manly, 1993) .
The fra-1 gene is non-identical to the osteosclerosis locus
The mapping data using the recombinant inbred strains revealed that fra-1 maps within the pericentromeric region of mouse chromosome 19 and thus to the same region of the genome which carries the osteosclerosis locus (oc) (Marks et al., 1985) . We therefore decided to test fra-1 as a candidate gene for oc. This mutation occured in a C57BL/6 stock and has been maintained in a hybrid genetic background between C57BL/6 and C3H called B6C3. Utilizing the SSLP between C57BL/ 6 and C3H for fra-1, we have genotyped 12 oc/oc mice, and all of them were homozygous for the C3H allele of fra-1. These data can be explained in 2 ways: ®rst, fra-1 and oc are two segregated, distinct loci, or second, the C57BL/6 stock in which oc occured is polymorphic at the fra-1 locus with our C57BL/6 stock. In the latter case, the tested oc/oc mice might only appear to carry the C3H allele of fra-1, although they in fact carry an aberrant C57BL/6 allele. Therefore, we mapped these two loci in an intercross between F1 individuals carrying oc, derived from an interspeci®c cross between a strain carrying oc in the B6C3 original background (oc/+), and a strain homozygous for the Mus spretus (SEG) chromosome 19. A total of 52 intercross progeny (F2) were produced and genotyped for fra-1. Out of 27 individuals used to estimate a genetic distance, no recombinants were observed between these 2 loci ( Table 3 ). The genetic interval was estimated at 14.3 cM (95% con®dence level), based on an intercross mapping calculation (Silver, 1995) . However, among the 25 remaining progeny, derived from informative recombinant individuals, three mice appear to be C3H homozygote at the fra-1 locus and oc/+, i.e.C57BL6/SEG heterozygote, at the oc locus. Thus, they carried at least one SEG allele of oc, but two C3H alleles of fra-1. These sets of recombinants hence argue in favor of the fact that fra-1 and oc are two dierent genes. To further address this question, we next tested whether the osteosclerosis mutation is allelic to a null mutation of fra-1 which we had previously generated via gene targeting in ES cells (details will be published later). Eight heterozygous fra-1 +/7 female mice, which are phenotypically normal and fertile, were crossed with two heterozygous oc/+ males. If oc were a mutant allele of fra-1, 25% of the ospring of these intercrosses (i.e. 37 out of 148 progeny obtained) oc/+mice were intercrossed as a control. Osteosclerosis phenotype was scored in each individual as lack of incisor eruption, circling behaviour, and lethality by day P25. M, male: F, female; n.d., not determined; n.a., not applicable would be expected to be fra-1 null /oc and hence to exhibit the osteosclerosis phenotype (Table 4) . As a control, the same two oc/+ males were crossed to two oc/+ females in parallel. Thirty-two ospring were obtained from these control crosses, six of which exhibited the osteosclerosis phenotype. These aected individuals showed a mild circling behaviour from 10 days after birth on, they were considerably smaller than their littermates, and died within 20 days after birth (Table 4 ). In contrast, none of the 148 ospring obtained from the fra-1
6oc/+ intercrosses exhibited this osteosclerosis phenotype, and they all survived to adulthood or at least to day P25, when some of them were killed (except three which were found missing shortly after birth).
Finally, three pairs of PCR primers were designed which allow the ampli®cation of a 461 bp fragment containing exon 1, a 592 bp fragment containing exon 2, and a 1014 bp fragment containing exon 3, intron 3 and the coding region of exon 4, respectively. Identical fragment sizes were obtained when genomic DNA from either wild-type or oc/oc mice was used as a template with each of the three primer pairs, indicating that the osteosclerosis mutation is not associated with any larger deletions or rearrangements within the coding region of fra-1 (data not shown).
Discussion
We have cloned and characterised the murine genomic locus of fra-1, an immediate early gene whose product is a component of the AP-1 transcription factor complex. Fra-1 and the three other members of the fos gene family (c-Fos, FosB, and Fra-2) share several regions in their coding sequences with signi®cant homology to each other, and it has been proposed that they may have diverged from a common ancestor gene (Cohen and Curran, 1988; Nishina et al., 1990; Lazo et al., 1991) . As similarities in the coding region might in part be due to functional conservation and coevolution, we extended this analysis to non-coding, structural aspects of the fos gene family and found that the general exon-intron distribution is very similar in all four fos genes. Perhaps most strikingly, the third exon is of identical size and encodes exactly the same part of the protein in all four genes. These data further support the hypothesis that the fos gene family has diverged from a single ancestral gene by gene duplication. However, the individual genes are not closely located to each other in the mouse genome, where fra-1 is on chromosome 19, c-fos on chromosome 12, and fosB on chromosome 7 (D 'Eustachio, 1984; Lazo et al., 1991) . The human fra-1 gene has been localised by`reverse mapping' to chromosome 11q13, a region which was found to be ampli®ed in a number of neoplastic disorders and contains the MEN1 gene, a putative tumor suppressor gene (Sinke et al., 1993; Tanigami et al., 1992; Brookes et al., 1992; Chandrasekharappa et al., 1997 ; The European Consortium on MEN1, 1997). We have mapped the mouse fra-1 gene to the pericentromeric region of chromosome 19, which is syntenic to that region of human chromosome 11.
Our sequence analysis revealed that fra-1 is a typical CpG-island gene, since a short region around the 5' end including the transcriptional start site, exon 1, and the trimeric AP-1 site in intron 1, is unusually rich in the dinucleotide sequence CG (Bird, 1987) . As is true for many CpG-island genes (Dynan, 1986) , no TATA box could be identi®ed in the fra-1 promotor region. Consistent with this ®nding, transcription starts heterogenously at three positions within a 7 bp element in the fra-1 gene (Bergers et al., 1995) . In that respect, the fra-1 gene diers from c-fos and fosB, which both have a TATA-box. In contrast to the transcribed region, the promoter architecture of fra-1 in general is not closely related to the c-fos and fosB promoters. c-Fos and FosB have several common promotor elements such as a serum response element (SRE), whose relative positions are also conserved, but which are absent in fra-1 (Lazo et al., 1991) .
These structural dierences are re¯ected in the unique transcriptional regulation of fra-1, which is subject to potent positive control by AP-1. Here we show that AP-1 activity seems to be not only sucient, but also necessary for fra-1 induction, since serum stimulation of fra-1 expression is delayed and greatly reduced in ®broblasts lacking c-Fos. Overall, the`c-fosdependent' part of the fra-1 induction kinetics is very similar to that of c-fos itself, but with a certain delay. This delay can be interpreted in a way that ®rst c-fos is upregulated, and then in turn upregulates fra-1 expression. The residual c-fos-independent induction of fra-1 at later time points could be mediated by other AP-1 components, or could be independent of AP-1 altogether. Interestingly, fra-1 is not serum-inducible at all in ®broblasts lacking c-Jun (MS and EFW, unpublished data). Since no serum response element has been found in the 5' region of the fra-1 gene (Bergers et al., 1995) , stimulation of fra-1 transcription by serum growth factors may thus be primarily an indirect eect, via induction of AP-1 acting on the putative TRE-containing enhancer in intron 1. This could also explain the delayed and protracted induction kinetics of fra-1 at a time when most other AP-1 proteins are already present at high levels.
Fra-1 exhibits three unique properties which would in theory enable it to act as a negative feedback regulator of AP-1. First, any increase in AP-1 activity will eventually lead to enhanced expression of Fra-1 due to the positive control of the fra-1 promoter by AP-1. Second, Fra-1 lacks a transactivation domain (Bergers et al., 1995) and can therefore limit the activity of the potent transactivators c-Fos and FosB by competing for Jun-proteins as dimerisation partners and sequestering them into DNA-bound AP-1 factors with low transcriptional activity. Third, induction of Fra-1 is delayed, but also remarkably longer lasting than that of other AP-1 proteins. It is therefore expected to exert its repressing function primarily at later stages of cellular stimulation, resulting in a transient rather than long-lasting activation of AP-1. Since long-lasting, constitutive activation of AP-1 can lead to cellular transformation, it is tempting to consider this proposed function of Fra-1 as tumor suppressor activity.
The strong control by AP-1 on fra-1 expression quali®es fra-1 as a potential endogenous`reporter gene' for AP-1 activity. In that respect, fra-1 has several advantages over the prototype AP-1 target gene, collagenase I, since it is expressed in most organs, whereas expression of collagenase is restricted to bone, muscle, and kidney, and it is also AP-1 induced considerably later than fra-1 (Gack et al., 1994; Angel and Karin, 1991) . To our knowledge, the enhancer element in intron 1 of the fra-1 gene constitutes the only non-arti®cial multimeric AP-1 site whose activity has been demonstrated (Bergers et al., 1995) , which might be important in view of the fact that e.g. JunB has been shown to function as transcriptional repressor on monomeric, but activator on multimerized AP-1 elements (Hsu et al., 1993; Angel and Karin, 1991) . Preliminary analysis suggests that fra-1 expression is indeed activated by JunB in transient transfection assays (R MuÈ ller and P Angel, personal communication).
At the outset of this work, we were intrigued by the possibility that fra-1 might be causally involved in the pathogenesis of the bone remodelling disease osteopetrosis. In osteosclerosis mice, a role of fra-1 was suggested by our ®nding that the mouse fra-1 gene maps to the same genomic region as the osteosclerosis (oc) locus (Marks et al., 1985; Franchi et al., unpublished) . In mice lacking c-Fos, we reasoned that fra-1 might be involved in the osteopetrosis phenotype because fra-1 expression appears to be subject to positive control by c-Fos and because Fra-1 can functionally replace c-Fos in osteoclast formation when overexpressed (K Matsuo, M Tonko and EFW, unpublished data). Therefore, we initially speculated that the osteopetrotic phenotype in mice lacking c-Fos might in part be due to reduced expression of fra-1 and that the actual gene mutated in osteosclerosis (oc/oc) mice might be fra-1. However, when we tested fra-1 as a candidate gene for oc, we reached the conclusion that fra-1 and oc are two closely linked, but nevertheless distinct genetic loci, and that a yet to be identi®ed gene other than fra-1 is mutated in osteosclerosis mice. Three independent lines of evidence support this conclusion: First, an independent mapping of fra-1 in an intercross between mice heterozygote for oc and carrying a Mus spretus chromosome 19 demonstrated that fra-1 and oc are two dierent genetic loci. Second, an allelism test performed by intercrossing mice heterozygous for the osteosclerosis mutation with mice heterozygous for a null mutation of fra-1 excluded that oc is a mutated allele of fra-1. Third, genomic DNA analysis showed that the osteosclerosis mutation is not associated with any detectable rearrangements within the coding region of fra-1. Whereas these ®ndings do not rule out the involvement of fra-1 in the pathogenesis of osteopetrosis, they provide strong evidence that fra-1 is not the gene that carries the critical disease-causing mutation in osteosclerosis mice.
Materials and methods

Cell culture
Wild-type and c-fos 7/7 ®broblasts (BruÈ sselbach et al., 1995) were cultured in DMEM supplemented with 10% fetal calf serum (FCS) and antibiotics. For serum stimulation experiments, subcon¯uent culture dishes were incubated 48 h in DMEM containing 0.5% FCS and then stimulated with medium containing 20% FCS for the indicated times prior to RNA isolation.
Cloning of genomic DNA and sequence analysis
A library from genomic DNA of the liver of a male 129/Sv mouse constructed in the cosmid vector pCos2EMBL was used (provided by Dr DP Barlow, NKI, Amsterdam). *10 6 colonies were screened with a randomly labelled 1.5 kb mouse fra-1 cDNA as previously described (StoÈ ger et al., 1993) . Four positive clones were isolated, and one of them, cosmid 22, was further characterised. A 4.5 kb ScaI fragment of cosmid 22 containing the 5' end and an overlapping 8.1 kb SalI/NotI fragment containing the 3' end of the fra-1 gene were subcloned into plasmid pBS KS II (Stratagene). From each subcloned plasmid, a series of deletion derivatives was generated and DNA sequence was determined by the dideoxy chain termination method with an ABI 373A automated sequencer (Perkin Elmer). Sequence alignment and analysis was performed with sequence editor (Perkin Elmer) and SecMan (DNAStar) software.
Genetic mapping
We have found a microsatellite (CA)n in the second intron of the mouse fra-1 gene (25 repeats in strain 129/Sv). Based on the genomic DNA sequence from the 129/Sv strain, we have selected a pair of primers allowing ampli®cation (2 mM MgCl 2 , annealing temperature 658C) of a fragment containing this microsatellite: 5'-AAGGCATGTGCCA-CACTATG-3'; 5'-GAGAGAACCAACCTCCAAGG-3' (Figure 2 ). The fragment length was found to be 134 bp with genomic DNA from mouse strains C57BL/6 and C57L, and 132 bp with AKR and C3H genomic DNA. This length polymorphism was utilized to map the mouse fra-1 gene with the help of the AKXL (between AKR and C57L) and BXH (between C57BL/6 and C3H) recombinant inbred strains (RIS) sets. PCR products were resolved by migration in a 5% Resophor gel (Eurobio) in 0.56TBE. Genomic DNA was prepared using a standard SDS/ proteinase K lysis procedure.
Mouse strains
Heterozygous osteosclerosis mice (B6C3Fe-a/a-oc) were purchased from the Jackson Laboratory, Bar Harbor, USA (JAX #536831). Mice heterozygous for a null allele of fra-1 (fra-1 +/7 ) were generated via gene targeting in embryonic stem (ES) cells (Schreiber, 1996) .
RNA isolation and Northern blot analysis
Total RNA from mouse tissues was prepared according to Chomczynski and Sacchi (1987) , and poly(A) + RNA was isolated by oligo(dT)-chromatography (Wang et al., 1991) . 2 ± 5 mg of poly (A) + RNA samples were electrophoresed in 0.9% agarose gels containing 16% formaldehyde and 16MOPS buer (20 mM MOPS, 5 mM sodium acetate, 0.5 mM EDTA, pH 7.0). Capillary transfer in 106SSC, prehybridization and hybridization was performed as described (Wang et al., 1991) .
